Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2018

Apr 20, 2018

33625_dirs_2018-04-19_1d7332d6-00dc-4c37-9c04-4d5451fd9b72.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2018-04-17

Reporting Person: Anderson Ray Benjamin M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-04-17 Common Stock M 1000 $43.21 Acquired 1000 Direct
2018-04-17 Common Stock S 1000 $139.82 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-04-17 Stock Option (right to buy) $43.21 M 1000 Disposed 2022-10-13 Common Stock (1000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4516 Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2017.

F2: Shares held of record by the Benjamin M. Anderson-Ray Revocable Living Trust (the "Trust"), of which the reporting person and his spouse are the trustees and beneficiaries. The reporting person has shared voting and investment power with respect to the shares held of record by the Trust.

F3: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option shall vest monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option is October 14, 2015.